M. Vilien
Impact in
- Genetics top 1%
- Inflammatory Bowel Disease
- Gastroenterology top 2%
- Gastroesophageal reflux and treatments
Papers in
- Co-authors
- Christer Grännö (4 shared papers)Anders Magnuson (4 shared papers)Per Karlén (4 shared papers)Erik Hertervig (4 shared papers)Per M. Hellström (4 shared papers)Hans Verbaan (4 shared papers)Ingalill Friis–Liby (3 shared papers)Magnus Ström (2 shared papers)
In The Last Decade
M. Vilien
33 papers receiving 1.8k citations
M. Vilien's Hit Papers
Peers
Comparison fields: 5 of 81
- Genetics 1.1k
- Gastroenterology 178
- Epidemiology 626
- Immunology 238
- Surgery 419
Countries citing papers authored by M. Vilien
This map shows the geographic impact of M. Vilien's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Vilien with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Vilien more than expected).
Fields of papers citing papers by M. Vilien
This network shows the impact of papers produced by M. Vilien. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Vilien. The network helps show where M. Vilien may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Vilien, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study Hit paper breakdown → | 2005 | 793 |
| 2 | 1992 | 143 | |
| 3 | 2015 | 142 | |
| 4 | 2010 | 132 | |
| 5 | 1987 | 97 | |
| 6 | 2016 | 82 | |
| 7 | 2004 | 57 | |
| 8 | A classification of human urothelial cells propagated in vitro. | 1985 | 47 |
| 9 | 2002 | 41 | |
| 10 | 1983 | 34 | |
| 11 | 1992 | 28 | |
| 12 | 1978 | 26 | |
| 13 | [Treatment of irritable bowel syndrome with peppermint oil. A double-blind study with a placebo]. | 1988 | 26 |
| 14 | 1990 | 23 | |
| 15 | 1980 | 22 | |
| 16 | 1992 | 22 | |
| 17 | 1997 | 21 | |
| 18 | 1973 | 16 | |
| 19 | 1981 | 15 | |
| 20 | A 2-year follow-up of the swedish-danish Infliximab/Placebo trial in steroid resistant acute ulcerative colitis | 2007 | 14 |
About M. Vilien
M. Vilien is a scholar working on Genetics, Surgery, Epidemiology, Gastroenterology and Oncology, having authored 33 papers that have together received 1.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (11 papers), Microscopic Colitis (7 papers), Immunotherapy and Immune Responses (5 papers), Gastroesophageal reflux and treatments (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Immune cells in cancer (3 papers), Liver Diseases and Immunity (3 papers) and Tissue Engineering and Regenerative Medicine (3 papers). The work is most often cited by research in Genetics (1.1k citations), Gastroenterology (178 citations), Epidemiology (626 citations), Immunology (238 citations) and Surgery (419 citations). M. Vilien has collaborated with scholars based in Denmark, Sweden and Norway. Frequent co-authors include Christer Grännö, Anders Magnuson, Per Karlén, Erik Hertervig, Per M. Hellström, Hans Verbaan, Ingalill Friis–Liby, Magnus Ström, Lars Blomquist and Gunnar Järnerot. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Gut, Alimentary Pharmacology & Therapeutics, Cancer Immunology Immunotherapy and The Journal of Urology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.